Chopas James George
VP/Chief Accounting Officer
Chopas James George has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 14, 2026.
On the most recent filing, Chopas James George is listed as VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. Inside the rolling window, Chopas James George reported no open-market purchases and 3 open-market sales totaling $79K in APLS. The largest disclosed transaction in the window is a sale of 2,064 APLS shares on Jan 22, 2026, worth $45K.
Companies traded
Other insiders at APLS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$79K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Chopas James George made?
Chopas James George has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.
Which companies does Chopas James George trade?
Chopas James George has filed SEC Form 4 disclosures for 1 company, including APLS.
When was Chopas James George's most recent SEC Form 4 filing?
Chopas James George's most recent SEC Form 4 filing on Tracefour is dated May 14, 2026.
What is Chopas James George's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chopas James George is listed as VP/Chief Accounting Officer.
What is Chopas James George's total buy and sell value in the current window?
Inside the rolling retention window, Chopas James George bought $0 and sold $79K based on SEC Form 4 filings.
What was Chopas James George's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,064 APLS shares on 2026-01-22, worth $45K, per SEC Form 4 filings.